Estimates Revisions ACADIA Pharmaceuticals Inc.
Stocks
ACAD
US0042251084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
After hours 01:54:19 | |||
| 27.15 USD | +6.01% |
|
24.92 | -8.20% |
| 08-05 | ACADIA Pharmaceuticals Q2 Earnings, Revenue Rise; Lifts 2026 Outlook | MT |
| 08-05 | Earnings Flash (ACAD) ACADIA Pharmaceuticals Posts Q2 EPS $0.18, vs. FactSet Est of $0.06 | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- ACAD Stock
- Consensus ACADIA Pharmaceuticals Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
